However, all of these genes have been detected in cells from all hematopoietic lineages or AML blasts, and CD148 and CD210 have even been recently suggested as novel immunotherapeutic targets in AML [34], except forCD261/TNFRSF10A which we did not find in previous publications pointing to implications in AML or APL. This evidence concerns the gene TNFRSF10A and acute promyelocytic leukemia.